Anthos Therapeutics, Inc.   Report issue

For profit Phase 2 Phase 3
Founded: Cambridge MA United States (2018)

Organization Overview

First Clinical Trial
2019
NCT04213807
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Anthos Therapeutics, Inc.